Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation CarriersElizabeth Page, Manuel R. Teixeira, Elizabeth Bancroft et al.|European Urology|2019Cited by 239
Gene panel testing of 5589 <i><scp>BRCA</scp>1/2</i>‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian CancerJan Hauke, Eric Hahnen, Gunnar Schmidt et al.|Cancer Medicine|2018Cited by 168
Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragilityIrene Catucci, Paolo Peterlongo, Ana Osório et al.|Genetics in Medicine|2017Cited by 93